Evaluation of biological characteristics in tumor vessels and clinical application of antagonistic agent for neovascularization
Evaluation of biological characteristics in tumor vessels and clinical application of antagonistic agent for neovascularization
批准号:
07457257
负责人:
KANEMATSU Takashi
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
研究背景近年来,有研究表明某些致癌促进剂具有促血管生成活性,而维甲酸及其衍生物通过抑制血管生成来抑制肿瘤的发生。这些报道表明血管生成在肿瘤发生中可能起重要作用。在临床环境中,血管生成对于肿瘤生长和转移至关重要。因此,我们进行了以下研究:1)研究血管生成因子与血管内皮细胞增殖活性之间的关系(EA-HY 926)使用结肠癌细胞、结肠癌肝转移细胞和人肝细胞癌细胞,并阐明TNT-α是否能够抑制血管生成2)研究PLC/PRF/5的血管生成活性(亚历山大)细胞的增殖活性。结果与结论1)结肠癌细胞和转移细胞的平均增殖活性分别为142%和152%。虽然不排除存在其他因素的可能性,但结肠癌细胞产生血管生成因子,例如原始癌细胞中的VEGF和转移细胞中的bFGF。2)亚历山大细胞能促进新生血管的形成,Ets- 1在新生血管内皮呈阳性表达。这些结果表明,肝细胞癌具有较强的促血管生成的增殖活性,Ets- 1可能在血管生成中起重要作用。
英文摘要
BackgroundRecently, it has been reported that a certain carcinogenetic promoter has an angiogenetic activity while retinoid and derivatives from vitamin D3 inhibit carcinogenesis thorough depression of angiogenesis. These reports indicate that angiogenesis may play an important role on carcinogenesis. In clinical settings, angiogenesis is crucial for tumor growth and metastasis. Thus, we investigate the following.Aims1) to examine relationship between angiogenetic factors and proliferative activity for vascular endothelium (EA-HY 926) using colon cancer cells, metastastatic cells of colon cancer to liver, and cells of human hepatocellular carcinoma, and to clarify whether TNT-alpha is able to inhibit angiogenesis or not2) to investigate the angiogenetic activity of PLC/PRF/5 (Alexander) cells, which is a human hepatoma cell line, with diffusion chamber assay using E 26 transformation-specific-1 (Ets-1)Results and Conclusion1) Mean proliferative activity of colon cancer cells and metastasized cells was l42 %, and l52 %, respectively. Although it was not ruled out of the possibility that there were other factors, colon cancer cells produced angiogenetic factors such as VEGF in original cancer cells and bFGF in the metastasized cells. TNF-alpha was not effective on inhibition of angiogenesis.2) Alexander cells accelerate angiogenesis in diffusion chamber assay and Ets- 1 was positive in the endothelium of the new vessels. These results suggest that hepatocellular carcinoma has strong proliferative activity for angiogenesis and Ets- 1 may play an important role on angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of transplantable self-regenerative liver tissue consisted of hepatocytes and stem cells
-
批准号:21659307
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2009
-
负责人:KANEMATSU Takashi
-
依托单位:
Studies on the role of PRIP in insulin secretion
-
批准号:18390494
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.55万
-
财政年份:2006
-
负责人:KANEMATSU Takashi
-
依托单位:
Analysis of the molecular mechanisms of GABA_A receptor assembly and trafficking.
-
批准号:15591969
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:KANEMATSU Takashi
-
依托单位:
Development of hepatocyte bank and hepatocyte transplantation with Decoy receptor 3 gene transfer
-
批准号:15390381
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.85万
-
财政年份:2003
-
负责人:KANEMATSU Takashi
-
依托单位:
Receptors for neurotransmitters in Auerbach's plexus of Hirschsprung's disease ; A comparison with animal models
-
批准号:09671237
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1997
-
负责人:KANEMATSU Takashi
-
依托单位:
Influence of hypoxia on migration potentiality and effect of antitumor drugs in human hepatoma all lines.
-
批准号:03454323
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.45万
-
财政年份:1991
-
负责人:KANEMATSU Takashi
-
依托单位:
Development of parenteral solution of modified amino acid metabolites to improve nutritional status in patients with cirrhosis
-
批准号:62480285
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.14万
-
财政年份:1987
-
负责人:KANEMATSU Takashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
纸箱生产线多设备PLC协同控制与智能优化系统研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:许昌亮
-
依托单位:
面向化工产线自动化的PLC控制软件开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐洪焱
-
依托单位:
基于PLC与机器视觉的嵌件注塑工艺动态调控与缺陷检测技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毕昆
-
依托单位:
“苦能坚阴”理论下黄连纳米外囊泡通过Gαgust/PLCβ2轴修复急性胰腺炎肠黏液屏障的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:秦百君
-
依托单位:
木犀草素调控GPR40/PLC/IP3R引起胞浆Ca2+浓度升高促进胰岛素分泌作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
丹酚酸B(SalB)通过GABAB/PLC/PKC/BDNF信号轴改善慢性疼痛伴抑郁的机制研究
-
批准号:2025JJ70454
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘欣欣
-
依托单位:
PLC- γ 1 通过调控肌肉因子介导“肌肉-脂肪间对话”来改
善机体胰岛素敏感性的作用机制研究
-
批准号:2024JJ6613
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:黎露莎
-
依托单位:
基于Syk/PLCγ2/PAD4调控NETs形成探讨仙连解毒方抑制结直肠癌
转移的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陶李蕙苹
-
依托单位:
NGF-PLC-PICK1信号轴经由ASIC3调控髓核干细胞适应退变椎间盘酸性微环境的机制研究
-
批准号:LY23H060007
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:韩斌
-
依托单位:
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
-
批准号:82301229
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陶天畅
-
依托单位: